24
Jul

Six biotechs were expected to go public this week, eyeing nearly $400 million combined, but that potential has so far amounted to one deeply discounted offering, one bottom-of-the-range debut and one outright cancelation.

…read more

Source: Biotech IPOs sputter amid downsizings, disappointments and white flags

    

0 No comments